Following antisense oligonucleotide-mediated knockdown of miR-21, induced or enhanced apoptotic responses in two NSCLC cell lines, H3255 and H441, suggested that miR-21 could also be a therapeutic target in resistant EGFR-mutant NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.